Pain BridgeMedicines & testing

CGRP-targeted preventive therapy measured, not guessed

Medication targeting the CGRP pathway implicated in migraine attacks, used to reduce attack frequency rather than treat an attack already underway.

What it is and how it works

Medication (monoclonal antibody or oral “gepant”) targeting the calcitonin gene-related peptide (CGRP) pathway implicated in migraine attacks, used to reduce attack frequency rather than treat an attack already underway.

  • Assessed first. We look at the whole pain pattern before recommending this.

  • Individualised. Dose, pace and progression are matched to you.

  • Reviewed. Progress is checked at follow-ups and the plan changes if it isn't working.

Where cgrp-targeted preventive therapy can help

Always prescribed after an assessment, as one part of a wider plan.

  1. 01Migraine & Cluster HeadacheMigraine and cluster headache are both recurring headache disorders, but they behave differently and are not treated the same way.

Two sides. A clearer picture.

In the clinic

How it's done

Typically administered as a monthly (or in some cases quarterly) subcutaneous self-injection, or, for one option, an intravenous infusion every three months, prescribed and monitored by the treating physician, with response typically assessed over the first two to three months of use.

Our approach

Why Pain Bridge

Selected individually based on the patient's diagnosed frequency and severity, in keeping with Pain Bridge's individualized-planning approach rather than a one-size-fits-all preventive default.

Questions, answered

What are the common side effects?

The most frequently reported is constipation; injection-site reactions and, less commonly, hair thinning have also been reported. Most people tolerate these medications well, with side-effect rates that are generally lower than many older oral preventive options.

How is this different from the medication I take once an attack has started?

CGRP-targeted preventive therapy is taken on a schedule to reduce how often attacks happen. It's a different drug class from triptans or other medications used to treat an attack already underway, and the two are often used together.

References

  1. Drellia K, Kokoti L, Deligianni CI, et al. Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. Cephalalgia, 2021. Source

Pain for months? Let's look properly.

  1. 1Book a visitChoose a time at our Delhi clinic.
  2. 2Full assessmentWe look at your whole pain pattern, not a single scan or test result.
  3. 3Your planYou leave with a plan, the reasoning behind it, and dates to review it.